Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score
about
Management before hepatectomy for hepatocellular carcinoma with cirrhosisTumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCCTwenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with or without a history of treatmentInternational validation of the Chinese university prognostic index for staging of hepatocellular carcinoma: a joint United Kingdom and Hong Kong studyThe Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy.Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.The Singapore Liver Cancer Recurrence (SLICER) Score for relapse prediction in patients with surgically resected hepatocellular carcinoma.Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolizationSerum manganese superoxide dismutase and thioredoxin are potential prognostic markers for hepatitis C virus-related hepatocellular carcinoma.A simple and effective prognostic staging system based on clinicopathologic features of intrahepatic cholangiocarcinoma.Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study.Factors impacting prognosis prediction in BCLC stage C and Child-Pugh class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy.Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysisPrognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaPhase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.Comparison of survival rates between patients treated with transcatheter arterial chemoembolization and hepatic resection for solitary hepatocellular carcinoma.Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaAlcohol, postprandial plasma glucose, and prognosis of hepatocellular carcinoma.Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy.Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experienceEvaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.Advanced hepatocellular carcinoma: which staging systems best predict prognosis?Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.Review of current staging systems for hepatocellular carcinoma.Review of 4th Single Topic Conference on HCC. Hepatocellular carcinoma: International consensus and controversies.Decreased apoptosis in advanced-stage/high-grade hepatocellular carcinoma complicating chronic hepatitis C is mediated through the downregulation of p21 rasManagement of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan.Interaction between periodontitis and liver diseasesA Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article.Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinomaPrognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.Evolving therapies in the treatment of hepatocellular carcinomaAdvances in prevention and diagnosis of hepatocellular carcinoma.
P2860
Q26783874-9DE0577B-36C3-403D-BAA0-BA040B155884Q27011253-68916C87-3399-424B-9058-82DEDFCA1F37Q33787850-F59B2144-D9C4-4D28-B80B-06E2A6B22888Q33845513-452D8A86-F8ED-4E2D-AFCE-8EAA6EB1D245Q33867307-70340D1E-E9CA-41EA-8375-734B93B99603Q34346779-995BB1E0-C117-4D7B-9D19-6741F99C0FE6Q34572243-8E6EB53F-C1F5-4843-8C20-87BB00923899Q34696921-227F81AD-998D-4A1C-9FCD-E04001B52AFBQ35073362-2640A11F-88DB-475C-BF8C-121CFC3D8C03Q35109504-FD04EA08-C67F-44FD-A386-BBBB242DABFBQ35113002-AE10E521-FDC9-4C1C-A5C9-09B236094CB0Q35114970-76E1D73E-F12E-48CC-9B30-9ECAFF9A9140Q35241955-F5A2162E-E027-42E8-A49E-C9BAF6792691Q35594248-B8D10BB8-F5BF-49B0-8A6C-82FEA83A9BE2Q35606927-AF87784F-72B8-4378-8EA3-BD7E574BB450Q35835285-3D1C1A2D-B227-4905-ADBF-8E59C78BD738Q36001102-CF1E036D-B7EF-4591-8250-5FC3D371A843Q36102833-692C81EF-5ABA-4439-A23C-25B62C3E8655Q36154018-51F59A29-45AA-45E3-A649-89452D6B23CAQ36194925-7BE47C5B-E219-4E9B-811E-8FD6904BE911Q36204431-D2CDCB54-C62E-4463-AA6B-A88C7545D02BQ36217074-9C89BDEA-9DC8-4FE6-A56F-C19A726C0DC7Q36299107-DD9A5BBB-8BD0-4970-8DD4-111E2B1CCCA5Q36525528-92C52158-EE7D-4679-808B-6B1AF8063BF8Q36541200-C431CD36-ECFF-43CE-A85C-FCE79502B25AQ36741673-A2EF1A22-0177-405C-A4E7-CB3508FC5D31Q36816413-CF03F38A-582E-448F-8A46-06FCA9559D53Q36836103-87764756-F115-4820-BD8B-9C7697227FD1Q36914691-449E5BC5-9F39-4D4C-BB4E-1236B18A9495Q36945069-4D9E10B8-F444-4ECB-868F-22FBD23E102EQ36945078-B909E20F-D464-439C-B596-12883551D344Q36967501-E0BA1DAF-557B-4CDD-9D13-6916BAD1DF0DQ37034867-B82E621B-AAE6-4D46-BCBF-3B024F463882Q37124700-43C560D3-2181-4071-8872-6C365ACBBE49Q37204278-D4F46991-A187-457E-A230-8808B07ADD40Q37206163-459F1C02-29EE-43B9-830A-756B1CEFBD80Q37240376-92E9AC97-3393-47AA-ACBC-A07C64221456Q37263149-C069E1ED-5FBD-410F-9DE8-C7BDF018FA52Q37290714-CB3EC7DA-B3FB-4375-A992-7C74ABC0033FQ37345951-9514E2BE-806B-4DB2-A395-EC48A09944E1
P2860
Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score
description
im Jahr 2004 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2004
@uk
name
Validation of a new prognostic ...... e compared with the CLIP score
@en
Validation of a new prognostic ...... e compared with the CLIP score
@nl
type
label
Validation of a new prognostic ...... e compared with the CLIP score
@en
Validation of a new prognostic ...... e compared with the CLIP score
@nl
prefLabel
Validation of a new prognostic ...... e compared with the CLIP score
@en
Validation of a new prognostic ...... e compared with the CLIP score
@nl
P2093
P356
P1433
P1476
Validation of a new prognostic ...... e compared with the CLIP score
@en
P2093
Hiroko Oka
Hiroshi Kasugai
Hobyung Chung
Seiji Haji
Takashi Matsunaga
Toshihito Seki
Yukio Osaki
P2860
P304
P356
10.1002/HEP.20486
P407
P577
2004-01-01T00:00:00Z